Adam J. Luginbuhl, MD
Professor
![Adam Luginbuhl](/content/academic/academics/colleges-schools-institutes/skmc/departments/otolaryngology/faculty/luginbuhl/_jcr_content/profile/image.img.jpg)
Contact
Adam J. Luginbuhl, MD
Professor
Education
Medical School
University of Connecticut School of Medicine
Residency
Thomas Jefferson University Hospital
Fellowship
Vanderbilt University
Publications
- Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma
- Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
- Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer
- A Survey of Microvascular Technique Preferences Among American Head Neck Society Members
- Differences in Functional and Survival Outcomes between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital